Oprah Winfrey, true to form, is forcing America to yet again grapple with a complex topic: weight loss. Her full-throated endorsement on national television last week for using GLP-1 drugs like Ozempic and Wegovy to treat obesity has opened the door for an important conversation about the use of these drugs for people struggling with their weight.
As a physician focused on obesity and metabolic disorders, I was troubled by Oprah’s support for these drugs. The show was framed as news, but sounded to me more like an hour-long infomercial. When it comes to GLP-1 drugs, there are some things prescribers know, more we’re just beginning to know, and plenty we don’t know yet.
Click this link for the original source of this article.
Author: Lisa Shah
This content is courtesy of, and owned and copyrighted by, https://www.statnews.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.